Biocon clears patent hurdle for breast cancer biosimilar Pebrilzo
Genentech patent settlement clears legal hurdles for Pebrilzo; competition and pricing will determine commercial gains
5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on www.business-standard.com — the content belongs to Business Standard.
